Regulation by Ca2+-signaling pathways of adenylyl cyclases

Cold Spring Harbor Perspectives in Biology

Volumn 3, Issue 1, 2011, Pages 1-22

  Halls, Michelle L ^a   Cooper, Dermot M F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCIUM; CYCLIC AMP; ISOPROTEIN;

BIOLOGICAL MODEL; CALCIUM SIGNALING; GENETICS; METABOLISM; PHYLOGENY; PHYSIOLOGY; REVIEW;

ADENYLATE CYCLASE; CALCIUM; CALCIUM SIGNALING; CYCLIC AMP; MODELS, BIOLOGICAL; PHYLOGENY; PROTEIN ISOFORMS;

EID: 84863873350     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a004143     Document Type: Article

References (124)

1. Anisimova M, Gascuel O. 2006. Approximate likelihoodratio test for branches: A fast, accurate, and powerful alternative. Syst Biol 55: 539-552.
2. 0-monophosphate signaling in anterior pituitary corticotrope cells: the role of adenylyl cyclase isotypes. Mol Endocrinol 17: 692-703.
3. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, Vogel Z. 1996. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβg. J Biol Chem 271: 21309-21315.
4. Böl G-F, Hülster A, Pfeuffer T. 1997b. Adenylyl cyclase type II is stimulated by PKC via C-terminal phosphorylation. Biochim Biophys Acta 1358: 307-313.
5. Böl G-F, Gros C, Hülster A, Bösel A, Pfeuffer T. 1997a. Phorbol ester-induced sensitisation of adenylyl cyclase type II is related to phosphorylation of threonine 1057. Biochem Biophys Res Comm 237: 251-256.
6. Belevych AE, Sims C, Harvey RD. 2001. ACh-induced rebound stimulation of L-type Ca(2+) current in guineapig ventricular myocytes, mediated by Gβg-dependent activation of adenylyl cyclase. J Physiol 536: 677-692.
7. Berridge MJ. 2006. Calcium microdomains: Organization and function. Cell Calcium 40: 405-412.
8. Berridge MJ. 1975. The interaction of cyclic nucleotides and calcium in the control of cellular activity. Adv Cyclic Nucleotide Res 6: 1-98.
9. 2+ mobilization in NCB-20 cells leading to direct inhibition of adenylyl cyclase. A novel mechanism for inhibition of cAMP production. J Biol Chem 266: 4995-5003.
10. Boyajian CL, Bickford-Wimer P, Kim MB, Freedman R, Cooper DMF. 1989. Pertussis toxin lesioning of the nucleus caudate-putamen attenuates adenylate cyclase inhibition and alters neuronal electrophysiological activity. Brain Res 495: 66-74.
11. Castresana J. 2000. Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol Biol Evol 17: 540-552.
12. Chakrabarti S, Wang L, Tang WJ, Gintzler AR. 1998. Chronic morphine augments adenylyl cyclase phosphorylation: Relevance to altered signaling during tolerance/dependence. Mol Pharmacol 54: 949-953.
13. Chen J, DeVivo M, Dingus J, Harry A, Li J, Sui J, Carty DJ, Blank JL, Exton JH, Stoffel RH, et al. 1995. A region of adenylyl cyclase 2 critical for regulation by G protein βg subunits. Science 268: 1166-1169.
14. 2+ channel activity in area CA1 of hippocampus. Proc Natl Acad Sci 88: 6467-6471.
15. Chevenet F, Brun C, Banuls A-L, Jacq B, Christen R. 2006. TreeDyn: Towards dynamic graphics and annotations for analyses of trees. BMC Bioinformatics 7: 439-447.
16. Cioffi DL, Moore TM, Schaack J, Creighton JR, Cooper DMF, Stevens T. 2002. Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase. J Cell Biol 157: 1267-1278.
17. 2+/calmodulin. Biochem J 278: 903-904.
18. Cooper DMF. 2003. Regulation and organization of adenylyl cyclases and cAMP. Biochem J 375: 517-529.
19. Cooper DMF, Crossthwaite AJ. 2006. Higher-order organization and regulation of adenylyl cyclases. Trends Pharmacol Sci 27: 426-431.
20. Cooper DMF, Mons N, Karpen JW. 1995. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374: 421-424.
21. 2+-sensitive adenylyl cyclases dictate their targeting to plasma membrane lipid rafts. J Biol Chem 280: 6380-6391.
22. Cumbay MG, Watts VJ. 2004. Novel regulatory properties of human type 9 adenylate cyclase. J Pharmacol Exp Ther 310: 108-115.
23. 2+/calmodulin-dependent pathway. Biochem Pharmacol 69: 1247-1256.
24. Dai S, Hall DD, Hell JW. 2009. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev 89: 411-452.
25. DeHaven WI, Jones BF, Petranka JG, Smyth JT, Tomita T, Bird GS, Putney JW. 2009. TRPC channels function independently of STIM1 and Orai1. J Physiol 587: 2275-2298.
26. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard J-F, Guindon S, LefortV, Lescot M, et al. 2008. Phylogeny. fr: Robust phylogenetic analysis for the nonspecialist. Nucl Acids Res 36: W465-469.
27. Dessauer CW. 2009. Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimensions in cAMP signaling. Mol Pharmacol 76: 1256-1264.
28. Diel S, Klass K, Wittig B, Kleuss C. 2006. Gβg activation site in adenylyl cyclase type II. Adenylyl cyclase type III is inhibited by Gβg. J Biol Chem 281: 288-294.
29. Dyachok O, Isakov Y, Sågetorp J, Tengholm A. 2006. Oscillations of cyclic AMP in hormone-stimulates insulinsecreting β-cells. Nature 439: 349-352.
30. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucl Acids Res 32: 1792-1797.
31. Efendiev R, Samelson BK, Nguyen BT, Phatarpekar PV, Baameur F, Scott JD, Dessauer CW. 2010. AKAP79 interacts with multiple adenylyl cyclase (AC) isoforms and scaffolds AC 5 and 6 to AMPA receptors. J Biol Chem doi 101074/jbcM110109769.
32. Evans T, Smith MM, Tanner LI, Harden TK. 1984. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms. Mol Pharmacol 26: 395-404.
33. 2+ entry sites. J Biol Chem 271: 12438-12444.
34. 2+ entry. J Biol Chem 273: 9297-9305.
35. 2+ entry requires localization in cholesterol-rich domains. J Biol Chem 275: 26530-26537.
36. 2+ entry. J Biol Chem 275: 40187-40194.
37. 2+-inhibitable adenylyl cyclase in C6-2B glioma cells. J Biol Chem 274: 12445-12453.
38. Federman AD, Conklin BR, Schrader KA, Reed RR, Bourne HR. 1992. Hormonal stimulation of adenylyl cyclase through Gi-protein βg subunits. Nature 356: 159-161.
39. 2+/calmodulin-insensitive adenylyl cyclase from rat brain. Proc Natl Acad Sci 88: 10173-10177.
40. Fischmeister R, Castro LRV, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, Vandecasteele G. 2006. Compartmentation of cyclic nucleotide signaling in the heart: The role of cyclic nucleotide phosphodiesterases. Circ Res 99: 816-828.
41. Gao BN, Gilman AG. 1991. Cloning and expression of a widely distributed (type IV) adenylyl cyclase. Proc Natl Acad Sci 88: 10178-10182.
42. Gao X, Sadana R, DessauerCW, Patel TB. 2007. Conditional stimulation of type Vand VI adenylyl cyclases by G protein βg subunits. J Biol Chem 282: 294-302.
43. 2+. J Neurochem 59: 1630-1639.
44. 2+-calmodulin-dependent phosphodiesterase 1A. J Biol Chem 279: 40494-40504.
45. 2+ spikes. Nature 418: 93-96.
46. Grunberger C, Obermayer B, Klar J, Kurtz A, Schweda F. 2006. The Calcium paradoxon of renin release: Calcium suppresses renin exocytosis by inhibition of calciumdependent adenylate cyclases AC5 and AC6. Circ Res 99: 1197-1206.
47. Gu C, Cooper DMF. 1999. Calmodulin-binding sites on adenylyl cyclase type VIII. J Biol Chem 274: 8012-8021.
48. Guillou JL, Nakata H, Cooper DMF. 1999. Inhibition by calcium of mammalian adenylyl cyclases. J Biol Chem 274: 35539-35545.
49. Guindon S, Gascuel O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
50. Hanoune J, Defer N. 2001. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 41: 145-174.
51. Haslauer M, Baltensperger K, Porzig H. 1998. Thrombin and phorbol esters potentiate Gs-mediated cAMPformation in intact human erythroid progenitors via two synergistic signaling pathways converging on adenylyl cyclase type VII. Mol Pharmacol 53: 837-845.
52. Hoffert JD, Chou CL, Fenton RA, Knepper MA. 2005. Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. J Biol Chem 280: 13624-13630.
53. Houslay MD. 2009. Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem Sci 35: 91-100.
54. 2+ of AC5 revealed by mutants and chimeric constructs. J Biol Chem 277: 33139-33147.
55. Iwami G, Kawabe J, Ebina T, Cannon PJ, Homcy CJ, Ishikawa Y. 1995. Regulation of adenylyl cyclase by protein kinase A. J Biol Chem 270: 12481-12484.
56. Jacobowitz O, Iyengar R. 1994. Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc Natl Acad Sci 91: 10630-10634.
57. Jacobowitz O, Chen J, Premont RT, Iyengar R. 1993. Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment. J Biol Chem 268: 3829-3832.
58. Kapiloff MS, Piggott LA, Sadana R, Li J, Heredia LA, Henson E, Efendiev R, Dessauer CW. 2009. An adenylyl cyclasemAKAPβ signaling complex regulates cAMP levels in cardiac myocytes. J Biol Chem 284: 23540-23546.
59. Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ, Ishikawa Y. 1994. Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 269: 16554-16558.
60. Krupinski J, Coussen F, Bakalyar HA, Tang WJ, Feinstein PG, Orth K, Slaughter C, Reed RR, Gilman AG. 1989. Adenylyl cyclase amino acid sequence: Possible channelor transporter-like structure. Science 244: 1558-1564.
61. Lai HL, Yang TH, Messing RO, Ching YH, Lin SC, Chern Y. 1997. Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response. J Biol Chem 272: 4970-4977.
62. 2+ and cAMP signaling in the insulin-secreting MIN6 β-cell line. J Biol Chem 280: 31294-31302.
63. Lariviere S, Garrel G, Simon V, Soh J-W, Laverriere J-N, Counis R, Cohen-Tannoudji J. 2007. Gonadotropinreleasing hormone couples to 3',5'-cyclic adenosine-5'-monophosphate pathway through novel protein kinase C-d and-1 in LβT2 gonadotrope cells. Endocrinology 148: 1099-1107.
64. Lefkimmiatis K, Srikanthan M, Maiellaro I, Moyer MP, Curci S, Hofer AM. 2009. Store-operated cyclic AMPsignalling mediated by STIM1. Nat Cell Biol 11: 433-442.
65. Lin TH, Lai HL, Kao YY, Sun CN, Hwang MJ, Chern Y. 2002. Protein kinase C inhibits type VI adenylyl cyclase by phosphorylating the regulatory N domain and two catalytic C1 and C2 domains. J Biol Chem 277: 15721-15728.
66. Lustig KD, Conklin BR, Herzmark P, Taussig R, Bourne HR. 1993. Type II adenylylcyclase integrates coincident signals from Gs, Gi, and Gq. J Biol Chem 268: 13900-13905.
67. Ma H, Green RD. 1992. Modulation of cardiac cyclic AMP metabolism by adenosine receptor agonists and antagonists. Mol Pharmacol 42: 831-837.
68. Mamluk R, Defer N, Hanoune J, Meidan R. 1999. Molecular identification of adenylyl cyclase 3 in bovine corpus luteum and its regulation by prostaglandin F2α-induced signaling pathways. Endocrinology 140: 4601-4608.
69. Marjamaki A, Sato M, Bouet-Alard R, Yang Q, Limon-Boulez I, Legrand C, Lanier SM. 1997. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. Integration of stimulatory and inhibitory input to the effector adenylyl cyclase. J Biol Chem 272: 16466-16473.
70. 2+ entry distinguished using adenylyl cyclase type 8. Mol Pharmacol 70: 769-777.
71. 2+ entry via Orai1 and stromal interacting molecule 1 (STIM1) regulates adenylyl cyclase type 8. Mol Pharmacol 75: 830-842.
72. 2+/calmodulin of type 1 and 8 adenylyl cyclases support their different physiological roles. J Biol Chem 284: 4451-4463.
73. Mou T-C, Masada N, Cooper DMF, Sprang SR. 2009. Structural basis for inhibition of mammalian adenylyl cyclase by calcium. Biochemistry 48: 3387-3397.
74. Nelson EJ, Hellevuo K, Yoshimura M, Tabakoff B. 2003. Ethanol-induced phosphorylation and potentiation of the activity of type 7 adenylyl cyclase. Involvement of protein kinase C d. J Biol Chem 278: 4552-4560.
75. Nicol X, Voyatzis S, Muzerelle A, Narboux-Neme N, Sudhof TC, Miles R, Gaspar P. 2007. cAMP oscillations and retinal activity are permissive for ephrin signaling during the establishment of the retinotopic map. Nat Neurosci 10: 340-347.
76. Nikolaev VO, Lohse MJ. 2006. Monitoring of cAMP synthesis and degradation in living cells. Physiology 21: 86-92.
77. Okumura S, Kawabe J-I, Yatani A, Takagi G, Lee M-C, Hong C, Liu J, Takagi I, Sadoshima J, Vatner DE, et al. 2003. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation. Circ Res 93: 364-371.
78. Ostrom RS, Liu X, Head BP, Gregorian C, Seasholtz TM, Insel PA. 2002. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 62: 983-992.
79. Pagano M, Clynes MA, Masada N, Ciruela A, Ayling L-J, Wachten S, Cooper DMF. 2009. Insights into the residence in lipid rafts of adenylyl cyclase AC8 and its regulation by capacitative calcium entry. Am J Physiol Cell Physiol 296: C607-619.
80. 2+ entry (SOCE). J Biol Chem 283: 17333-17340.
81. Patel HH, Murray F, Insel PA. 2008. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 48: 359-391.
82. Piggott LA, Bauman AL, Scott JD, Dessauer CW. 2008. The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain. Proc Natl Acad Sci 105: 13835-13840.
83. Premont RT, Chen J, Ma HW, Ponnapalli M, Iyengar R. 1992. Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases. Proc Natl Acad Sci 89: 9809-9813.
84. Premont RT, Matsuoka I, Mattei MG, Pouille Y, Defer N, Hanoune J. 1996. Identification and characterization of a widely expressed form of adenylyl cyclase. J Biol Chem 271: 13900-13907.
85. Rasmussen H. 1981. In Calcium and cAMPas synarchic messengers. John Wiley and Sons, Inc., New Jersey. Rhim J-H, Jang I-S, Yeo E-J, Song K-Y, Park SC. 2006. Role of protein kinase C-dependent A-kinase anchoring proteins in lysophosphatidic acid-induced cAMP signaling in human diploid fibroblasts. Aging Cell 5: 451-461.
86. 2+: Molecular determinants and functional consequences. Physiol Rev 86: 369-408.
87. Robison GA, Butcher RW, Sutherland EW. 1971. In Cyclic AMPAcademic Press, New York.
88. Roy J, Lefkimmiatis K, Moyer MP, Curci S, Hofer AM. 2010. The v-3 fatty acid eicosapentaenoic acid elicits cAMP generation in colonic epithelial cells via a 'store-operated' mechanism. Am J Physiol Gastrointest Liver Physiol 299: G715-G722.
89. Sadana R, Dessauer CW. 2009. Physiological roles for G protein-regulated adenylyl cyclase isoforms: Insights from knockout and overexpression studies. Neurosignals 17: 5-22.
90. Sadana R, Dascal N, DessauerCW. 2009. N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer. Mol Pharmacol 76: 1256-1264.
91. Schaefer ML, Wong ST, Wozniak DF, Muglia LM, Liauw JA, Zhuo M, Nardi A, Hartman RE, Vogt SK, Luedke CE, et al. 2000. Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice. J Neurosci 20: 4809-4820.
92. 2+ entry pathways in HEK293 cells. J Biol Chem 274: 31174-31178.
93. 2+ entry. J Biol Chem 277: 6025-6031.
94. Steiner D, Saya D, Schallmach E, Simonds WF, Vogel Z. 2006. Adenylyl cyclase type-VIII activity is regulated by Gβg subunits. Cell Signal 18: 62-68.
95. Storm DR, Hansel C, Hacker B, Parent A, Linden DJ. 1998. Impaired cerebellar long-term potentiation in type I adenylyl cyclase mutant mice. Neuron 20: 1199-1210.
96. Straub SV, Wagner LE, Bruce JI, Yule DI. 2004. Modulation of cytosolic calcium signaling by protein kinase Amediated phosphorylation of inositol 1,4,5-trisphosphate receptors. Biol Res 37: 593-602.
97. Sunahara RK, Dessauer CW, Gilman AG. 1996. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36: 461-480.
98. Tang WJ, Gilman AG. 1991. Type-specific regulation of adenylyl cyclase by G protein βg subunits. Science 254: 1500-1503.
99. Tang T, Gao MH, Lai NC, Firth AL, Takahashi T, Guo T, Yuan JX-J, Roth DM, Hammond HK. 2008. Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation 117: 61-69.
100. Tesmer JJ, Sunahara RK, Gilman AG, Sprang SR. 1997. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsα. GTPgS. Science 278: 1907-1916.
101. Tesmer JJ, Sunahara RK, Johnson RA, Gosselin G, Gilman AG, Sprang SR. 1999. Two-metal-ion catalysis in adenylyl cyclase. Science 285: 756-760.
102. Trubey KR, Culpepper S, Maruyama Y, Kinnamon SC, Chaudhari N. 2006. Tastants evoke cAMP signal in taste buds that is independent of calcium signaling. Am J Physiol Cell Physiol 291: C237-244.
103. Villacres EC, Wong ST, Chavkin C, Storm DR. 1998. Type I adenylyl cyclase mutant mice have impaired mossy fiber long-term potentiation. J Neurosci 18: 3186-3194.
104. Vorherr T, Knopfel L, Hofmann F, Mollner S, Pfeuffer T, Carafoli E. 1993. The calmodulin binding domain of nitric oxide synthase and adenylyl cyclase. Biochemistry 32: 6081-6088.
105. Wachten S, Masada N, Ayling L-J, Ciruela A, Nikolaev VO, Lohse MJ, Cooper DMF. 2010. Distinct pools of cAMP centre on different isoforms of adenylyl cyclase in pituitary-derived GH3B6 cells. J Cell Sci 123: 95-106.
106. Wang H-Y, Burns LH. 2006. Gβg that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein. J Neurobiol 66: 1302-1310.
107. Wang H, Gong B, Vadakkan KI, Toyoda H, Kaang BK, Zhuo M. 2007. Genetic evidence for adenylyl cyclase 1 as a target for preventing neuronal excitotoxicity mediated by N-methyl-D-aspartate receptors. J Biol Chem 282: 1507-1517.
108. Wang HY, Friedman E, Olmstead MC, Burns LH. 2005. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in m opioid receptor-G protein coupling and Gβg signaling. Neuroscience 135: 247-261.
109. 2+ stimulation of cAMP accumulation in mouse parotid acini. J Biol Chem 275: 14691-14699.
110. Wayman G, Wei J, Wong S, Storm D. 1996. Regulation of type I adenylyl cyclase by calmodulin kinase IV in vivo. Mol Cell Biol 16: 6075-6082.
111. Wei J, Wayman G, Storm DR. 1996. Phosphorylation and inhibition of type III adenylyl cyclase by calmodulindependent protein kinase II in vivo. J Biol Chem 271: 24231-24235.
112. Wei J, Zhao AZ, Chan GCK, Baker LP, Impey S, Beavo JA, Storm DR. 1998. Phosphorylation and inhibition of olfactory adenylyl cyclase by CaM kinase II in neurons: A mechanism for attenuation of olfactory signals. Neuron 21: 495-504.
113. Weitmann S, Schultz G, Kleuss C. 2001. Adenylyl cyclase type II domains involved in Gβg stimulation. Biochemistry 40: 10853-10858.
114. 2+ stimulation of adenylyl cyclase generates dynamic oscillations in cyclic AMP. J Cell Sci 119: 828-836.
115. 2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol Rev 87: 965-1010.
116. Willoughby D, Cooper DMF. 2008. Live-cell imaging of cAMP dynamics. Nat Methods 5: 29-36.
117. 2+-dependent cAMP synthesis in pancreatic and neuronal systems. J Biol Chem doi 101074/jbcM110120725.
118. Wu ZL, Thomas SA, Villacres EC, Xia Z, Simmons ML, Chavkin C, PalmiterRD, Storm DR. 1995. Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci 92: 220-224.
119. Xu TR, Vyshemirsky V, Gormand A, von Kriegsheim A, Girolami M, Baillie GS, Ketley D, Dunlop AJ, Milligan G, Houslay MD, et al. 2010. Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species. Sci Signal 3: ra20.
120. Yoshimura M, Cooper DMF. 1993. Type-specific stimulation of adenylyl cyclase by protein kinase C. J Biol Chem 268: 4604-4607.
121. Yoshimura M, Ikeda H, Tabakoff B. 1996. m-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase. Mol Pharmacol 50: 43-51.
122. Yu HJ, Ma H, Green RD. 1993. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes. Mol Pharmacol 44: 689-693.
123. Zaccolo M. 2006. Phosphodiesterases and compartmentalized cAMP signalling in the heart. Eur J Cell Biol 85: 693-697.
124. Zimmermann G, Taussig R. 1996. Protein kinase C alters the responsiveness of adenylyl cyclases to G protein α and βg subunits. J Biol Chem 271: 27161-27166.